Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02643849 · ClinicalTrials.gov registry record · NA

Use of The Spanner Temporary Prostatic Stent as an Alternative to a Urinary Catheter to Achieve Bladder Drainage in Men

A NA study of Urinary Retention, sponsored by SRS Medical.

Completed
Registry status
NA
Development phase
107
Enrollment target
6
Study locations

NCT02643849 is a NA study of Urinary Retention that has completed, run by SRS Medical. The registered enrollment target is 107 participants, below the 130-participant average among 11 other Urinary Retention trials with a reported enrollment target (18% lower). The trial reports 6 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02643849, a NA study of Urinary Retention, has completed, sponsored by SRS Medical.

COMPLETED
Registry status
NA
Development phase
107 participants
Enrollment target
6
Study locations

Study Summary

The Spanner is being evaluated for use to manage voiding dysfunction and lower urinary tract symptoms in subjects to achieve bladder drainage in men unfit for other treatments.

Conditions Studied

Interventions

  • DEVICE The Spanner Temporary Prostatic Stent

Study Locations (6)

Florida

  • Atlantic Urology - Daytona Beach
  • Advanced Urology Specialists - Oxford
  • Urology Specialists of West Florida - Palm Harbor
  • Pinellas Urology Inc - South Pasadena

Massachusetts

  • Greater Boston Urology - Hingham

New York

  • Brooklyn Urology Research Group - Brooklyn

Trial Details

FieldValue
Enrollment Target 107 participants
Start Date 2016-08
Est. Completion 2019-02
Phase NA

Sponsor

SRS Medical

1 total trials

What the Registry Record Tells You About NCT02643849

The ClinicalTrials.gov registry entry for NCT02643849 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 130-participant average among 11 other Urinary Retention trials with a reported enrollment target (18% lower). The listed sponsor is SRS Medical, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Urinary Retention appearing as the primary indexed condition, and to 1 intervention - of which The Spanner Temporary Prostatic Stent is the first listed.

NCT02643849 reports 6 study locations spanning 3 distinct geographic areas - top geographies include Florida, Massachusetts, New York.

Frequently Asked Questions

What is clinical trial NCT02643849 about?

NCT02643849 is a clinical study titled "Use of The Spanner Temporary Prostatic Stent as an Alternative to a Urinary Catheter to Achieve Bladder Drainage in Men". The Spanner is being evaluated for use to manage voiding dysfunction and lower urinary tract symptoms in subjects to achieve bladder drainage in men unfit for other treatments.

What is the current status of trial NCT02643849?

This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2016-08. Estimated completion is 2019-02.

What conditions does trial NCT02643849 study?

This clinical trial studies the following conditions: Urinary Retention.

What interventions are being tested in trial NCT02643849?

The interventions under investigation include: The Spanner Temporary Prostatic Stent (DEVICE).

Who is sponsoring clinical trial NCT02643849?

This trial is sponsored by SRS Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02643849 being conducted?

This trial has 6 study locations across Florida, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urinary Retention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.